Matthew Winton
Overview
Matthew Winton received $2M in total compensation, including $326K in salary, at Inozyme Pharma in 2023.
Source: SEC filing on April 26, 2024.
Related executives
We found seven more executives who work or worked at Inozyme Pharma.
Douglas Treco
Inozyme Pharma
Chief Executive Officer
Axel Bolte
Inozyme Pharma
Chief Executive Officer
Sanjay Subramanian
Inozyme Pharma
Chief Financial Officer
Henric Bjarke
Inozyme Pharma
Chief Operating Officer
Deborah Wenkert
Inozyme Pharma
Chief Medical Officer
Steven Jungles
Inozyme Pharma
Former Senior Vice President and Chief Technical Operations Officer
Pedro Huertas
Inozyme Pharma